MPS Limited Board Approves FY26 Audited Results; Appoints KPMG as Internal Auditors
MPS Limited's Board approved audited FY26 results with an unmodified auditor's opinion. No final dividend recommended for FY26 due to acquisition funding. KPMG appointed as Internal Auditors for three years (FY27-FY29). Walker Chandiok & Co LLP re-appointed as Statutory Auditors for five years (post-56th AGM to 61st AGM).
The appointment and re-appointment of auditors, along with the approval of financial results, are standard corporate governance and reporting activities. While important for compliance and transparency, they do not represent a significant strategic shift or immediate financial impact beyond routine operations.
The announcement covers routine financial reporting and auditor appointments, with no significant positive or negative financial performance indicators highlighted. The decision not to pay a dividend is explained by strategic capital allocation.
MPS Limited announced that its Board of Directors, in a meeting held on May 15, 2026, approved the audited financial results for the Fourth Quarter (Q4) and the Financial Year ended March 31, 2026. The results, both standalone and consolidated, received an unmodified opinion from the statutory auditors, M/s. Walker Chandiok & Co LLP. The Board also decided not to recommend a final dividend for the financial year 2025-26, citing the deployment of cash flow towards the acquisition of Unbound Medicine, Inc. and the need to retain capital for growth.
Furthermore, the Board approved the appointment of M/s. KPMG Assurance and Consulting Services LLP (KPMG) as the Internal Auditors for the Company and its material subsidiary, MPS Interactive Systems Limited. This appointment is for a term of three consecutive financial years, commencing from FY 2026-27 up to FY 2028-29. The move aims to ensure alignment in the internal audit framework across the Group.
Additionally, M/s. Walker Chandiok & Co LLP has been re-appointed as the Statutory Auditors of the Company and its material subsidiary for a second term of five consecutive years, commencing from the conclusion of the upcoming 56th AGM until the conclusion of the 61st AGM in 2031, subject to shareholder approval. These re-appointments are intended to ensure consistency in audit methodology and reporting standards at the Group level.
The Board meeting commenced at 10:30 hours and concluded at 13:55 hours on May 15, 2026.
What to do with a filing like this
MPS Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by MPS Limited. Read the original for the full detail.